DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,036 | +10.4% | 19,391 | +48.8% | 0.01% | -20.0% |
| Q4 2022 | $362,336 | -19.1% | 13,029 | -10.8% | 0.01% | -23.1% |
| Q3 2022 | $448,000 | -0.4% | 14,607 | -4.4% | 0.01% | -7.1% |
| Q2 2022 | $450,000 | +67.9% | 15,285 | +187.5% | 0.01% | +27.3% |
| Q3 2021 | $268,000 | -64.2% | 5,317 | -44.3% | 0.01% | -65.6% |
| Q2 2021 | $748,000 | -48.1% | 9,539 | -62.2% | 0.03% | -50.0% |
| Q1 2021 | $1,441,000 | +126.6% | 25,241 | +232.3% | 0.06% | +204.8% |
| Q4 2020 | $636,000 | – | 7,595 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |